Literature DB >> 28813240

When Does Therapeutic Misconception Affect Surrogates' or Subjects' Decision Making about Whether to Participate in Dementia Research?

Laura B Dunn1, Barton W Palmer2.   

Abstract

"Therapeutic misconception" (TM) refers to inappropriate assumptions and beliefs on the part of research participants regarding key distinctions between the purpose, methods, intended benefits, and potential disadvantages of research compared to those of clinical care. Despite an extensive literature describing TM across varied types of research and populations, minimal work has addressed TM in the context of dementia research. This is a serious gap, for several reasons: people with dementia are at significant risk of diminished capacity; surrogate decision makers are typically asked to provide consent on behalf of the person with dementia; and available treatments for dementia are quite limited. More research is needed on the prevalence, nature, and impact of TM in the context of clinical dementia research.
© 2017 American Medical Association. All Rights Reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28813240     DOI: 10.1001/journalofethics.2017.19.7.nlit1-1707

Source DB:  PubMed          Journal:  AMA J Ethics


  5 in total

1.  Planning Ahead for Dementia Research Participation: Insights from a Survey of Older Australians and Implications for Ethics, Law and Practice.

Authors:  Nola Ries; Elise Mansfield; Rob Sanson-Fisher
Journal:  J Bioeth Inq       Date:  2019-07-11       Impact factor: 1.352

2.  Procedural Framework to Facilitate Hospital-Based Informed Consent for Dementia Research.

Authors:  Timothy R Holden; Sarah Keller; Alice Kim; Michael Gehring; Emily Schmitz; Carol Hermann; Andrea Gilmore-Bykovskyi; Amy J H Kind
Journal:  J Am Geriatr Soc       Date:  2018-09-24       Impact factor: 5.562

3.  Informed consent, therapeutic misconception, and clinical trials for Alzheimer's disease.

Authors:  James M Wilkins; Brent P Forester
Journal:  Int J Geriatr Psychiatry       Date:  2020-01-26       Impact factor: 3.485

4.  Ethical and Methodological Considerations for Evaluating Participant Views on Alzheimer's and Dementia Research.

Authors:  Clark Benson; Amanda Friz; Shannon Mullen; Laura Block; Andrea Gilmore-Bykovskyi
Journal:  J Empir Res Hum Res Ethics       Date:  2020-11-26       Impact factor: 1.742

5.  Positive Attitudes and Therapeutic Misconception Around Hypothetical Clinical Trial Participation in the Huntington's Disease Community.

Authors:  Kristina Cotter; Carly E Siskind; Sharon J Sha; Andrea K Hanson-Kahn
Journal:  J Huntingtons Dis       Date:  2019
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.